ArticlePDF Available

Comparison of modified Glasgow-Imrie, Ranson, and Apache II scoring systems in predicting the severity of acute pancreatitis

Authors:

Abstract

Aim: The course of acute pancreatitis is variable with patients at risk of poor outcomes. The purpose of this study was to compare Modified Glasgow-Imrie, Ranson, and APACHE II scoring systems in predicting the severity of acute pancreatitis. Material and Methods: After a brief history, clinical examination and qualifying inclusion criteria, 70 patients (41 women, 29 men) diagnosed with acute pancreatitis were included in the study. The three scores were calculated for each patient and evaluated for their role in the assessment of specific outcomes. Results: 34.3% patients were diagnosed with severe acute pancreatitis, while 65.7% patients had mild acute pancreatitis. A strong positive correlation was found between all the prognostic scores and the severity of disease. In the prediction of the severity of disease according to AUC, it was found that Glasgow-Imrie score had an AUC of 0.864 (0.756–0.973), followed very closely by APACHE II score with an AUC of 0.863 (0.758–0.968). APACHE II had the highest sensitivity (79.17%) in predicting severity while Glasgow-Imrie score was the most specific (97.83%) of all the scores. Patients with a Glasgow-Imrie score above the cut-off value of 3 had more complications and a longer hospital stay. Conclusion: The Glasgow-Imrie score was comparable to APACHE II score and better than Ranson score statistically in predicting the severity of acute pancreatitis. Its administration in predicting the severity of acute pancreatitis is recommended.
DOI: 10.5604/01.3001.0015.8384 POL PRZEGL CHIR 2022: 94: 1-7 AHEAD OF PRINT
original article
1
Comparison of modified Glasgow-Imrie, Ranson,
and Apache II scoring systems in predicting the severity
of acute pancreatitis
Rohit Chauhan
ABCE
, Neeraj Saxena
AD
, Neeti Kapur
F
, Dinesh Kumar Kardam
D
Department of General & Minimally Invasive Surgery, Atal Bihari Vajpayee Institute of Medical Sciences & Dr. Ram Manohar Lohia
Hospital, New Delhi, India
Article history: Received: 12.08.2021 Accepted: 28.04.2022 Published: 02.05.2022
ABSTRACT: Aim: The course of acute pancreatitis is variable with patients at risk of poor outcomes. The purpose of this study was to
compare Modified Glasgow-Imrie, Ranson, and APACHE II scoring systems in predicting the severity of acute pancreatitis.
Material and Methods: Ater a brief history, clinical examination and qualifying inclusion criteria, 70 patients (41 women,
29 men) diagnosed with acute pancreatitis were included in the study. The three scores were calculated for each patient and
evaluated for their role in the assessment of specific outcomes.
Results: 34.3% patients were diagnosed with severe acute pancreatitis, while 65.7% patients had mild acute pancreatitis.
A strong positive correlation was found between all the prognostic scores and the severity of disease. In the prediction of the
severity of disease according to AUC, it was found that Glasgow-Imrie score had an AUC of 0.864 (0.756–0.973), followed very
closely by APACHE II score with an AUC of 0.863 (0.758–0.968). APACHE II had the highest sensitivity (79.17%) in predicting
severity while Glasgow-Imrie score was the most specific (97.83%) of all the scores. Patients with a Glasgow-Imrie score above
the cut-of value of 3 had more complications and a longer hospital stay.
Conclusion: The Glasgow-Imrie score was comparable to APACHE II score and better than Ranson score statistically in
predicting the severity of acute pancreatitis. Its administration in predicting the severity of acute pancreatitis is recommended.
KEYWORDS: APACHE II, Glasgow-Imrie, prognostic scores, Ranson, severe acute pancreatitis
ABBREVIATIONS
ANC – Acute necrotic collection
AP – Acute Pancreatitis
APACHE II – Acute Physiology and Chronic Health Evaluation II
APFC – Acute peripancreatic fluid collection
AUC – Area Under the Curve
CECT – Contrast-Enhanced Computed Tomography
HDU – High Dependency Unit
ICU – Intensive Care Unit
NPV – Negative Predictive Value
PPV – Positive Predictive Value
ROC – Receiver Operating Characteristic
USG – Ultrasonography
INTRODUCTION
Acute Pancreatitis (AP) is an inflammation of the pancreatic and
peripancreatic tissue with the clinical course ranging from amild,
self-limiting disease in most patients to severe, multiple organ
dysfunction in very few [1–3]. AP occurs due to an abnormal ac-
tivation of pancreatic enzymes resulting in the autodigestion of
the pancreatic parenchyma [4]. is leads to alocal as well as sys-
temic inflammatory response. ere is arelease of pro-inflam-
matory cytokines and anti-inflammatory mediators. All these
mediators cause increased permeability and damage to the mi-
crocirculation of the pancreas [5]. e cascade of inflammation
is self-limiting in approximately 80–90% of all patients. However,
in the remaining few, there is amassive release of inflammatory
mediators into the systemic circulation leading to amultiple organ
dysfunction syndrome and rarely, death of the patient [1].
Confirmation of AP is done by history, clinical findings, and raised
levels of pancreatic enzymes in the plasma. Rise of amylase or li-
pase of more than 3 times its normal levels is confirmatory of the
diagnosis of AP [6]. To evaluate the pancreas, contrast-enhanced
computed tomography (CECT) is the best modality for imaging,
especially for the assessment of complications such as sterile or
infected peripancreatic fluid collections, pancreatic necrosis, pan-
creatic pseudocyst, pancreatic-pleural fistulas, and vascular com-
plications [7–9]. Surgical intervention may sometimes be needed
for these complications. Image-guided aspiration or necrosec-
tomy may be performed in infected pancreatic necrosis. Surgi-
cal debridement and drainage may also be needed in pancreatic
abscesses if it fails to respond to percutaneous catheter drainage
and antibiotics. Pseudocysts may rarely require drainage by lapa-
roscopic and endoscopic means [10].
e variable course of the disease ranging from mild AP to severe
AP with ahigh rate of mortality in the severe form, necessitates
early and accurate prediction of severity to strategize its manage-
ment [1]. Athorough assessment of the severity of disease is also
important to predict prolonged hospitalization, complications, and
to prevent mortality.
e severity of AP was divided into 3 categories by the Revised Atlan-
ta classification (2012) [11]. When organ failure or local or systemic
Authors’ Contribution:
A – Study Design
B – Data Collection
C – Statistical Analysis
D – Data Interpretation
E – Manuscript Preparation
F – Literature Search
WWW.PPCH.PL
2
original article
Invasive Surgery at Atal Bihari Vajpayee Institute of Medical Scienc-
es & Dr. Ram Manohar Lohia Hospital, New Delhi, India between
the 1st November 2018 and 31st March 2020.
Inclusion criteria
All patients aged > 18 years who presented to our centre and di-
agnosed as AP were included in the study. e diagnostic criteria
were the presence of any 2 out of the following three criteria – (a)
history of pain in the abdomen radiating to the back and relieved
on bending forward associated with tenderness/guarding in the
upper abdomen, (b) elevation over 3 times the upper normal limit
of serum amylase (normal range – 30 to 110 U/L)/serum lipase
(normal range – 23 to 300 U/L), and (c) radiographic evidence
– USG (Ultrasonography) or CECT findings suggestive of AP
such as pancreatic oedema, pancreatic necrosis, peripancreatic
fluid collections.
Exclusion criteria
e exclusion criteria were – (a) recurrent AP, (b) chronic pan-
creatitis (± calcific), and (c) patients not willing to participate in
the study.
Atotal of 70 patients diagnosed with AP were included in the study
after taking an informed and written consent from the patient.
Adetailed history was taken and clinical examination was carried
out as per written proforma. All the biochemical parameters were
complications were absent, it was classified as mild AP. Transient
organ failure that resolved within 48 h was classified as moderately
severe AP. Persistent organ failure for ≥ 48 h was termed severe AP.
Several prognostic markers have been developed for severity grad-
ing in AP. Multifactorial scoring systems that take into account
clinical and biochemical criteria for severity stratification have been
used for the past many years. ese include the criteria described
by Ranson in the 1970s [12, 13], the Acute Physiology and Chronic
Health Evaluation (APACHE II) score in 1981 [1, 14], and the modi-
fied Glasgow-Imrie score in 1984 [15]. Various studies have been
conducted in the past to identify the best predictor of severity in
AP but with conflicting results and thus no ideal single method for
assessing the severity in AP.
is study was conducted to find out ascoring system that provides
an early as well as accurate prediction of the severity of the disease.
Aprognostic score that is easy to calculate and convenient to use for
practical purposes, is desired. e scores were evaluated for their
assessment of severity, complication rates, mortality and length of
hospital stay in case of AP.
MATERIAL AND METHODS
With the approval of the Ethics Committee, aprospective obser-
vational study was carried out on patients who were clinically sus-
pected to have AP, in the Department of General and Minimally
Fig. 1. Demographic features and incidence of severe disease, mortality and complications.
0
5
10
15
20
25
20-30 30-40 40-50 50-60 60-70 >70
NUMBER OF PATIENTS
AGE GROUP (IN YEARS)
Male Female Incidence of severe disease Complications Mortality
3
POL PRZEGL CHIR 2022: 94: 1-7 AHEAD OF PRINT
original article
noted at the time of admission and after 48 hours of admission.
Severity of the disease was classified as per Atlanta Classification at
48 hours after admission. e modified Marshall score was used to
assess organ failure [16, 17]. CECT of the abdomen was done after
72 hours of admission in all patients with moderate or severe AP.
e modified Glasgow-Imrie score, Ranson score and APACHE II
score were calculated. e outcome measures were severity, mor-
tality, complications and length of hospital stay. All patients were
followed up in the outpatient department at 3 months.
Statistics
e data was entered in MS EXCEL spreadsheet and analysis was
done using Statistical Package for Social Sciences (SPSS) version
21.0. Categorical variables were presented in numbers and percent-
ages (%) and continuous variables were presented as mean ± SD and
median. e scores were correlated with the outcomes, that is, se-
verity, mortality, complications and length of hospital stay statisti-
cally using two-by-two contingency tables, odds ratio, Chi-square
test, Fisher’s Exact test & Mann-Whitney-Utest. AP-value of < 0.05
was considered statistically significant. Predictive accuracy of each
score was determined by AUC (Area Under the Curve) in the ROC
(Receiver Operating Characteristic) analysis.
RESULTS
Epidemiology
e mean and median age of the patients included was 41.6 years
and 40 years respectively. e oldest patient was 72 years old and
the youngest person was 23 years old. ere were 62.8% (n = 44) of
patients in the range of 30–50 years. Afemale predominance with
a1.41:1 ratio i.e. 58.6% females (n = 41) and 41.4% males (n = 29)
was observed. e mean age was 40.7 years in males and 42.2 years
in females. e most common aetiology was gall stones (77.14%),
followed by alcohol intake (17.14%). e cause for the rest 5.71%
of patients was idiopathic.
The incidence of severe disease in the study group was 34.3%
(n = 24) as calculated by the Revised Atlanta criteria [11]. e remain-
ing, 65.71% (n = 46) of the patients had amild form of AP. e compli-
cations that were encountered were acute peripancreatic fluid collec-
tion (APFC) and acute necrotic collection (ANC) with an incidence of
28.6% (n = 20). Of the 15 patients with APFC, 80% (n = 12) had aspon-
taneous resolution of the collection at the 3-month follow-up. Only
3 patients had apersistent fluid collection in the form of pseudocyst. All
3 underwent surgical intervention in the form of internal drainage. Four
out of the 5 patients with ANC died. Only 1 patient with awalled-off
necrosis underwent surgical intervention after his 3-month follow-up.
Surgical intervention was done for persistent symptoms in only 5.7%
(n = 4) of patients, all of whom had severe AP.
Patients were also stratified by the type of organ failure according
to the modified Marshall scoring system [16, 17]. Out of the 24 pa-
tients who had severe AP, 17 patients had only asingle organ sys-
tem failure and 7 had multiple organ failure persistent beyond 48
hours. Majority of patients with persistent single organ failure had
an acute kidney injury reflected by their raised serum creatinine.
e mean and median length of hospital stay was 6.2 days (+ 2.9
days) and 5 days respectively. e mean length of hospital stay was
SCORE PATIENTS WITH AP % (N) SEVERE AP % (N) MORTALITY % (N) COMPLICATIONS % (N) MEAN LENGTH OF HOSPITAL
STAY ( DAYS )
Ranson Score
<3 72.9 (51) 10 (7) - 11.4 (8) 5.46
≥3 27.1 (19) 24.3 (17) 7.1 (5) 17.1 (12) 8.10
Total 100 (70) 34.3 (24) 7.1 (5) 28.6 (20) 6.21
Glasgow-Imrie Score
<3 72.9 (51) 8.6 (6) - 12.9 (9) 5.77
≥3 27.1 (19) 25.7 (18) 7.1 (5)15.7 (11)7.59
Total 100 (70) 34.3 (24)7.1 (5) 28.6 (20) 6.21
APACHE II Score
<8 68.6 (48) 7.1 (5) 1.4 (1) 10 (7) 5.13
≥8 31.4 (22) 27.2 (19) 5.7 (4) 18.6 (13) 8.43
Total 100 (70) 34.3 (24) 7.1 (5) 28.6 (20) 6.21
SENSITIVITY SPECIFICITY PPV NPV ACCURACY
Ranson Score 70.83 95.65 89.47 86.27 87.14
Glasgow-Imrie Score 75 97.83 94.74 88.24 90.00
APACHE II 79.17 93.48 86.36 89.58 88.57
Tab. I. Incidence of severe AP, mortality, complications, and length of hospital stay stratified among diferent scoring systems.
Tab. II. Sensitivity, Specificity, PPV, NPV, and Accuracy of diferent scoring systems for severe AP.
PPV – Positive Predictive Value; NPV – Negative Predictive Value. All values are expressed in percentage.
WWW.PPCH.PL
4
original article
e sensitivity, specificity, PPV (Positive Predictive Value), NPV
(Negative Predictive Value) and accuracy for predicting the
incidence of severe disease is depicted in Tab. II. It was observed
that APACHE II score had the highest sensitivity, of 79.17%, in
terms of the incidence of severe disease. Ranson and Glasgow-
-Imrie scores had asensitivity of 70.83% and 75% respectively.
Among the three scores, Glasgow-Imrie had the highest specific-
ity, of 97.83%. Ranson and APACHE II had aspecificity of 95.65%
and 93.62% respectively.
In Tab. III., the degree of association between the outcomes and the
categories of the scoring systems has been shown. e Chi-square
test showed that the incidence of severe disease was higher with all
the three scoring systems when avalue higher than the cut-off was
attained. Glasgow-Imrie score had the strongest correlation in pre-
dicting the severity of AP with an odds ratio of 135. Similar observa-
tions were made in terms of mortality and complications. As there
was no mortality when the score was less than the cut-off value, the
odds ratio for Ranson and Glasgow-Imrie scores could not be calcu-
lated. However, by Fisher’s exact test there was significant evidence
(P < 0.05) of higher mortality in the group with ascore above the
cut-off values. APACHE II score had an odds ratio of 10.44 and P
= 0.031 (significant) by Fisher’s exact test in predicting mortality.
In predicting complications, acomparable odds ratio of 9.21, 6.42,
and 8.46 was found for the Ranson, Glasgow-Imrie, and APACHE
II scores respectively, indicating that the three scores were almost
equivalent in predicting complications.
From the results of the Mann-Whitney Utest, it could be conclud-
ed that the mean length of hospital stay was significantly higher for
patients with ascore above the cut-off value.
longer in patients with asevere disease (8.1 days + 3 days) as com-
pared to those with amild form of the disease (5.2 days + 2 days).
ere was amortality of 7.14% (n = 5) and in all cases where mor-
tality was confirmed, the disease was of severe type. e mean age
of mortality was 57.6 (+ 10.7) years. Fig. 1. shows the distribution of
the three outcomes – severity, mortality and complications – strati-
fied by age groups and gender.
Prognostic scores
As shown in Tab. I., it was observed that out of all patients, 34.3%
(n = 24) had asevere form of the disease. In this subset, 24.3%
(n = 17) had aRanson score above its cut-off value, that is ≥3.
Similarly, 25.7% (n = 18) had aGlasgow Imrie score ≥3 and 27.2%
(n = 19) of the patients had an APACHE II score ≥ 8, i.e. above their
respective cut-off values.
Mortality as an outcome was observed in 7.1% (n = 5) of the cases.
All 5 cases had aRanson and Glasgow-Imrie score of more than their
cut-off values of 3. Out of these 5 cases, only 4 had an APACHE II
score above its cut-off value of 8.
Complications were observed in 28.6% (n = 20) of the cases where
17.1% (n = 12) had aRanson score ≥3, 15.7% (n = 11) had aGlasgow-
-Imrie score ≥3, and 18.6% (n = 13) had an APACHE II score ≥8.
e mean length of hospital stay was found to be 6.2 days (3.3 to 9.1
days) with alonger length of stay observed in patients with ascore
above the cut-off value for each scoring system.
Tab. I. depicts the cross-tabulations among the scoring systems and
the outcomes.
SCORES SEVERITY MORTALITY COMPLICATIONS LENGTH OF STAY
Ranson 53.43a**** 9.21a6 versus 8 days
(P < 0.0001) b(P = 0.001) c(P = 0.0009) b(P < 0.001) d
Glasgow- 135a**** 6.42a6 versus 8 days
-Imrie Score (P < 0.0001) b(P = 0.001) c(P = 0.0009) b(P = 0.020) d
APACHE II 54.47a10.44a8.46a5 versus 8 days
(P < 0.0001) b(P = 0.031) c (P = 0.0001) b(P < 0.001) d
AUC (% CI) SEVERITY MORTALITY COMPLICATIONS
Ranson Score 0.832a (0.716–0.949)b0.892 (0.809–0.975) 0.730 (0.588–0.872)
(0.059)c(0.044) (0.073)
Glasgow-Imrie Score 0.864 (0.756–0.973) 0.892 (0.809–0.975) 0.695 (0.549–0.841)
(0.055) (0.108) (0.075)
APACHE II 0.863 (0.758–0.968) 0.762 (0.547–0.976) 0.735 (0.596–0.874)
(0.054) (0.110) (0.071)
Tab. III. Extent of correlation of scores with the outcomes.
Tab. IV. AUC of diferent scores in predicting severity, mortality, and complications.
a Odds ratio; b Chi-square test; c Fisher's exact test; d Mann-Whitney test; significance was tested at 5%.**** Odds ratio not calculated.
a Area under the curve; b Confidence Interval; c Standard Error.
5
POL PRZEGL CHIR 2022: 94: 1-7 AHEAD OF PRINT
original article
In the prediction of the severity of the disease according to AUC
(with 95% Confidence Interval) in the ROC curve, it was found
that Glasgow-Imrie score had an AUC of 0.864 (0.756– 0.973), fol-
lowed very closely by APACHE II score with an AUC of 0.863 (0.758
–0.968). Ranson score had an AUC of 0.832 (0.716–0.949). Similarly,
the ROC curves were plotted for mortality and complications, and
their AUC was calculated as depicted in Table 4.
e area under the ROC curve (AUC) is an indicator of the prob-
ability of correct or accurate prediction by the test of severity, mor-
tality, complications. An AUC of 1 represents aperfect test whereas
an AUC of 0.5 represents aworthless test.
Fig. 2. depicts different ROC curves. Since the incidence of
mortality above the cut-off values for Ranson and Glasgow-
Imrie score are equal, the ROC curves overlap each other,
and thus have an equal AUC of 0.892 (0.809–0.975). APACHE
II had an AUC of 0.762 (0.547–0.976) which is less than the
other 2 scoring systems.
DISCUSSION
e wide variability in the clinical course of AP ranging from amild
form to multiple organ failure and death led to the development
of various prognostic scores to assess the disease severity. In this
study, an analysis of the scoring systems against the outcomes was
done to tag the most appropriate scoring system for predicting the
outcomes studied.
APACHE II score had the highest sensitivity – of 79.17% – in pre-
dicting the severity of AP followed by Glasgow-Imrie and Ranson
scoring systems with asensitivity of 75% and 70.83% respectively
(Tab. II.). e high sensitivity of APACHE II could be attributed to
the greater number of physiological parameters needed to calculate
it, as compared to the other two scores. APACHE II score also had
avery high accuracy as well as NPV making it suitable to rule out
asevere form of AP rather than predicting it. Serial calculation of
APACHE II at regular intervals would probably make it even more
sensitive and specific to predict the severity in AP. Marco Simoes
et al. reported asimilar high sensitivity (79.4%), NPV (91.2%) and
AUC (0.861) for APACHE II score [18].
Glasgow-Imrie score was the most specific of all the scores. e
difference in the sensitivity of Glasgow-Imrie score and APACHE
II was not high. e odds of having severe AP were high when the
score was higher than the cut-off value, as depicted by asignifi-
cantly high odds ratio. Although the AUC for Glasgow-Imrie score
was the highest of all three scores, it was comparable to the AUC
of APACHE II score. Both scores were equally good predictors of
severity of pancreatitis but the difference in the ability of the two
scores i.e., Glasgow-Imrie and APACHE II, to predict the severity
of disease was negligible.
e two scores were thus comparable to each other in predicting
the severity of disease. However, the ease of calculation of Glasgow-
Imrie score makes it amore favourite choice. Ranson score was the
least useful in predicting the severity of AP in our study. e find-
ings were consistent with the study by Savio G. Barreto in which
the author concluded that APACHE II and Glasgow-Imrie scores
were comparable to each other in predicting the severity of AP [19].
A
B
C
Fig. 2. ROC curves for predicting (A) incidence of severe AP, (B) mortality, and (C)
complications.
ROC Curve
1 - Specicity
1 - Specicity
1 - Specicity
Source of the Curve
RANSON SCORE
GLASGOW-IMRIE SCORE
APACHE II SCORE
Reference Line
SensitivitySensitivitySensitivity
Source of the Curve
RANSON SCORE
GLASGOW-IMRIE SCORE
APACHE II SCORE
Reference Line
Source of the Curve
RANSON SCORE
GLASGOW-IMRIE SCORE
APACHE II SCORE
Reference Line
ROC Curve
ROC Curve
WWW.PPCH.PL
6
original article
is result was congruous with the studies of Marco Simoes et al.
[18] and Ajay Khanna [20].
ere has been asignificant advancement in imaging techniques
such as CECT and endoscopic ultrasound which can help in the
assessment of disease accurately. However, the availability of such
methods of imaging is limited to tertiary care centres in metro-
politan areas only. e scoring systems can prove to be helpful in
planning the management of acute pancreatitis in acountry like
ours where the majority of the population resides in rural areas
with limited access to affordable healthcare. e data from our
study exhibit that the Glasgow-Imrie and APACHE II scoring sys-
tems are comparable to each other in predicting the severity of AP.
Ranson score lags behind the other two scores in predicting the
severity of the disease. However, regarding mortality, Glasgow-
Imrie and Ranson scores were equally capable of, and better than
APACHE II score in predicting the outcome. All the three scores
were similar to each other in predicting complications in patients
with AP. Ascore above the cut-off values in each scoring system
was predictive of asignificantly prolonged length of hospital stay.
CONCLUSION
AP can prove to be acritical and life-threatening disease which re-
quires careful consideration in its management. For the prediction
of severe disease, mortality, and complications in patients, various
scores such as the Ranson, Glasgow-Imrie, and APACHE II were
used. All the scores had apositive correlation with the outcomes
in our study. Both Glasgow-Imrie and APACHE II scores were
comparable to each other in predicting the incidence of severe
disease. Ranson score was less sensitive and accurate compared to
the other two scores. e calculation of APACHE II score is based
on alarge number of parameters and is in itself cumbersome to
calculate. Also, APACHE II score was initially designed to prog-
nosticate any patient admitted to the intensive care unit and not
for AP specifically, in contrast to Glasgow-Imrie score which was
specifically fashioned for AP.
Glasgow-Imrie score is, therefore, recommended for predicting
severe AP. e score is sensitive and specific enough to use it as an
indicator of asevere form of the disease. Asimple and accurate pre-
diction of severity will help in proper management of patients with
acute pancreatitis, prevent adverse events such as mortality and
make satisfactory use of hospital resources such as HDU and ICU.
REFERENCES
1. Mederos M.A., Reber H.A., Girgis M.D.: Acute Pancreatitis: A Review. JAMA,
2021; 325(4): 382–390. doi: 10.1001/jama.2020.20317.
2. Portelli M., Jones C.D.: Severe acute pancreatitis: pathogenesis, diagnosis and
surgical management. Hepatobiliary Pancreat Dis Int., 2017; 16(2): 155–159. doi:
10.1016/s1499-3872(16)60163-7. PMID: 28381378.
3. Lee P.J., Papachristou G.I.: New insights into acute pancreatitis. Nat Rev Gastro-
enterol Hepatol., 2019; 16(8): 479–496. doi: 10.1038/s41575-019-0158-2. PMID:
31138897.
4. Norman J.: Role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg ,
1998; 1(175): 76–83.
5. Yadav D., Lowenfels A.B.: e epidemiology of pancreatitis and pancreatic cancer.
Gastroenterology, 2013; (6)144: 1252–1261.
6. Alter D., Koch D.D.: A Review of Acute Pancreatitis. JAMA, 2021; 325(23): 2402.
doi: 10.1001/jama.2021.6012.
7. Ortiz Morales C.M., Girela Baena E.L., Olalla Muñoz J.R., Parlorio de Andrés E.,
López Corbalán J.A.: Radiology of acute pancreatitis today: the Atlanta classifi-
cation and the current role of imaging in its diagnosis and treatment. Radiologia
(Engl Ed), 2019; 61(6): 453–466. English, Spanish. doi: 10.1016/j.rx.2019.04.001.
Epub 2019 May 29. PMID: 31153603.
8. Aghdassi A.A., S eidensticker M.: Bildgebende Diagnostik bei akuter Pankreatitis
[Imaging diagnostics in acute pancreatitis]. Internist (Berl), 2021; 62(10): 1044–1054.
German. doi: 10.1007/s00108-021-01153-3. Epub 2021 Sep 15. PMID: 34524469.
9. Brizi M.G., Perillo F., Cannone F., Tuzza L., Manfredi R.: e role of imaging in
acute pancreatitis. Radiol Med, 2021; 126(8): 1017–1029. doi: 10.1007/s11547-021-
01359-3. Epub 2021 May 12. PMID: 33982269; PMCID: PMC8292294.
10. Tyberg A., Karia K., Gabr M. et al.: Management of pancreatic fluid collections:
A comprehensive review of the literature. World J Gastroenterol, 2016; 22(7):
2256–2270. doi: 10.3748/wjg.v22.i7.2256. PMID: 26900288; PMCID: PMC4735000.
In predicting mortality, APACHE II score had asignificantly high
odds ratio of 10.44 predicting ahigher odd of mortality in patients
with ascore above the cut-off value. e odds ratio could not be
calculated for Ranson and Glasgow-Imrie scores as there was no
mortality in patients with ascore less than the cut-off value. Ran-
son and Glasgow-Imrie score had an equal AUC which was more
than the AUC of APACHE II. An equal AUC for both the scores
suggested that both scores were equally capable of predicting mor-
tality in AP. Ajay Khanna reported asimilar AUC for Glasgow-
Imrie and Ranson score in predicting mortality, however the au-
thor found that APACHE II had agreater AUC than the other 2
scores [20]. e modest difference in this finding could be due to
the small sample size in both studies.
Complications such as APFC and ANC were seen in 28% of pa-
tients. e odds ratio for predicting complications was 9.21, 6.42,
and 8.46 for the Ranson, Glasgow-Imrie, and APACHE II scoring
systems respectively. All values were significant with aP < 0.05 de-
noting ahigher chance of having complications in patients with
ascore above the cut-off value. e difference in AUC of the three
scores was also not substantial. is finding related to predicting
complications concurs with the finding of Ajay Khanna [20]. e
AUC for the three scores regarding complications in the same or-
der was found to be 0.70, 0.64, 0.68 by Ajay Khanna in his study.
us, each score was at par with each other in predicting compli-
cations. In the study by Marco Simoes et al., the author found no
significant correlation between the prognostic scores and inci-
dence of complications [18]. e difference in the etiological fac-
tors leading to the difference in the occurrence of complications
could be the cause for this digression.
e mean length of hospital stay in patients with AP was found
to be shorter as compared to studies by Marco Simoes et al. [18]
and Ajay Khanna [20]. Both authors found amean length of stay
of 10 days. In patients with severe AP, the values for the length of
hospital stay were falsely low in our study. e data was skewed
towards the lower value as all the deaths in severe AP took place
within 4 to 6 days of admission. Also, most patients in our study
with severe AP had asingle organ failure in the form of acute kid-
ney injury which responded well within aweek to adequate re-
suscitation. However, this outcome could vary in different stud-
ies depending upon the level of care, monitoring, as well as the
management conducted by the health-care staff of the hospi-
tal. e length of hospital stay was significantly prolonged for all
the three systems when the score was above their cut-off values.
7
POL PRZEGL CHIR 2022: 94: 1-7 AHEAD OF PRINT
original article
11. Banks P.A., B ollen T.L ., Dervenis C. et al.: Acute Pancreatitis Classification Wor-
king Group. Classification of acute pancreatitis 2012: revision of the Atlanta clas-
sification and definitions by international consensus. Gut, 2013; 62(1): 102–111.
doi: 10.1136/gutjnl-2012-302779. Epub 2012 Oct 25. PMID: 23100216.
12. Ranson J.H., Rifkind K.M., Roses D.F., Fink S.D., Eng K., Spencer F.C.: Prognostic
signs and the role of operative management in acute pancreatitis. Surg Gynecol
Obstet, 1974; 139(1): 69–81.
13. Ranson J.H.: e timing of Índices de Gravidade. Ann Surg, 1979; 189(5): 654–663.
14. Knaus W.A ., Draper E.A., Wagner D.P., Zimmerman J.E .: APACHE II: a severity of
disease classification system. Crit Care Med, 1985; 13(10): 818–829.
15. Blamey S.L., Imrie C.W., O’Neill J., Gilmour W.H., Carter D.C.: Prognostic factors
in acute pancreatitis. Gut, 1984; 25(12): 1340–1346.
16. Marshall J.C., Cook D.J., Christou N.V. et al.: Multiple organ dysfunction score:
a reliable descriptor of a complex clinical outcome. Crit Care Med, 1995; 23 (10):
1638–1652.
17. Siregar G.A., Siregar G.P.: Management of Severe Acute Pancreatitis. Open Access
Maced J Med Sci., 2019; 7(19): 3319–3323. doi: 10.3889/oamjms.2019.720. PMID:
31949538; PMCID: PMC6953950.
18. Simoes M., Alves P., Esp erto H. et al.: Predicting Acute Pancreatitis Severity: Com-
parison of Prognostic Scores. Gastroenterology Re search, 2011; 4(5): 216–222.
19. Barreto S.G., Rodrigues J.: Comparison of APACHE II and Imrie Scoring Systems
in predicting the severity of Acute Pancreatitis. World J Emerg Surg, 2007; 2: 33.
20. Khanna A.K., Meher S., Prakash S. et al.: Comparison of Ranson, Glasgow, MOSS,
SIRS, BISAP, APACHE-II, CTSI Scores, IL-6, CRP, and Procalcitonin in Predicting
Severity, Organ Failure, Pancreatic Necrosis, and Mortality in Acute Pancreatitis.
HPB Surg, 2013; 2013: 367581.
https://ppch.pl/resources/html/articlesList?issueId=0 Page of count: 7 Tables: 4 Figures: 2 References: 20
Some right reserved: Fundacja Polski Przegląd Chirurgiczny. Published by Index Copernicus Sp. z o. o.
The authors declare that they have no competing interests.
The content of the journal „Polish Journal of Surgery” is circulated on the basis of the Open Access which means free
and limitless access to scientic data.
This material is available under the Creative Commons – Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).
The full terms of this license are available on: https://creativecommons.org/licenses/by-nc/4.0/legalcode
Dr. Rohit Chauhan (ORCID: 0000-0002-7998-0827); Department of General & Minimally Invasive Surgery, Atal Bihari
Vajpayee Institute of Medical Sciences & Dr. Ram Manohar Lohia Hospital, New Delhi, India; Phone: +91 9650065206;
E-mail: rohitchauhan93@yahoo.com
Chauhan R., Saxena N., Kapur N., Kardam D.K.: Comparison of modied Glasgow-Imrie, Ranson, and Apache II scoring systems
in predicting the severity of acute pancreatitis; Pol Przegl Chir 2022; 94: (1–7); DOI: 10.5604/01.3001.0015.8384
Table of content:
Copyright:
Competing interests:
Corresponding author:
Cite this article as:
... Currently, various commonly used scoring systems, including the Acute Physiology and Chronic Health Evaluation (APACHE-II), the Balthazar CT Severity Index, as well as the Bedside Index for Severity in AP (BISAP) [8][9][10], are utilized to evaluate AP severity and forecast patient outcomes. However, these systems often rely heavily on a combination of clinical, imaging, and laboratory parameters, which can make them complex and time-consuming. ...
Article
Full-text available
Background Both blood urea nitrogen (BUN) and creatinine (Cr) are indicators of kidney function, and the BUN/Cr ratio has been identified as an independent prognostic marker for adverse outcomes in critically ill patients with various conditions. However, the relationship between the BUN/Cr ratio and long-term mortality in critically ill patients with acute pancreatitis (AP) remains unclear. Hence, the primary objective of this study was to determine the prognostic value of the BUN/Cr ratio in patients with AP. Methods We conducted a retrospective cohort study using data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. The primary exposure variable was the BUN/Cr ratio at intensive care unit (ICU) admission, and the primary outcome was 365-day all-cause mortality. Kaplan–Meier analyses and multivariate Cox proportional hazards models were used to assess this relationship, while restricted cubic spline (RCS) was used to explore potential non-linear associations. In addition, subgroup analyses were conducted to assess consistency between groups. Results A total of 850 critically ill patients with AP were included, with a mean age of 59.61 years, 58.59% male, and an overall 365-day mortality rate of 20.94%. Patients in the highest BUN/Cr quartile had significantly higher mortality rates compared to those in lower quartiles. Multivariate Cox regression analysis demonstrated that, even after adjusting for potential confounders, an elevated BUN/Cr ratio remained an independent predictor of increased 28-day and 365-day mortality. RCS analysis confirmed a J-shaped relationship between the BUN/Cr ratio and 28-day and 365-day mortality, with a sharp increase in the risk of death above the 16.80 threshold. Subgroup analysis indicated that this association was consistent across various patient characteristics. Conclusion This study identified a non-linear relationship between the BUN/Cr ratio and 365-day mortality in critically ill patients with AP, suggesting that the BUN/Cr ratio may serve as an easily accessible, cost-effective, and accurate prognostic marker for this population.
... At present, the commonly used scoring systems for assessing the severity and prognosis of AP in clinical prac- tice include Ranson score, APACHE-II score, BISAP score, Balthazar score, CTSI score, and Sequential Organ Failure Assessment (SOFA) score [37][38][39][40][41]. Ranson score, which is the first AP scoring system created, assesses AP based on patient condition changes in the first 48 hours after admission and is determined by 11 objective indexes, including five indexes at admission (age, WBC, GLU, serum lactate dehydrogenase, and AST) and six indexes at 48 hours after admission (Ca 2+ , HCT, BUN, arterial oxygen saturation, acid-base balance, and fluid loss) [42]. ...
... [3][4][5] The Acute Physiology and Chronic Health Examination (APACHE) II, a complex score which was originally developed to estimate intensive care unit (ICU) mortality, has been extensively used for AP severity prediction due to its ability to be calculated at any time during a patient's hospital stay, often outperforming older ones. [6][7][8] The Bedside Index of Severity in AP (BISAP), developed more recently, offers similar advantages to APACHE II by eliminating the need for a 48-h interval. The BISAP score has less variables which are cost-effective and can be done in emergency setting. ...
Article
Full-text available
OBJECTIVES Traditional scoring systems have been widely used to predict acute pancreatitis (AP) severity but have limitations in predictive accuracy. This study investigates the use of machine learning (ML) algorithms to improve predictive accuracy in AP. METHODS A retrospective study was conducted using data from 101 AP patients in a tertiary hospital in Türkiye. Data were preprocessed, and synthetic data were generated with Gaussian noise addition and balanced with the ADASYN algorithm, resulting in 250 cases. Supervised ML models, including random forest (RF) and XGBoost (XGB), were trained, tested, and validated against traditional clinical scores (Ranson’s, modified Glasgow, and BISAP) using area under the curve (AUC), F1 score, and recall. RESULTS RF outperformed XGB with an AUC of 0.89, F1 score of 0.82, and recall of 0.82. BISAP showed balanced performance (AUC = 0.70, F1 = 0.44, and recall = 0.85), whereas the Glasgow criteria had the highest recall but lower precision (AUC = 0.70, F1 = 0.38, and recall = 0.95). Ranson’s admission criteria were the least effective (AUC = 0.53, F1 = 0.42, and recall = 0.39), probable because it lacked the 48 th h features. CONCLUSION ML models, especially RF, significantly outperform traditional clinical scores in predicting adverse outcomes in AP, suggesting that integrating ML into clinical practice could improve prognostic assessments.
... Các bảng điểm là tập hợp của nhiều chỉ số của bệnh nhân, khi phối hợp sẽ cho giá trị tiên lượng cao hơn một chỉ số NGAL huyết tương là hợp lý. Kết quả của chúng tôi cũng tương tự nghiên cứu Rohit Chauhan của AUC của Imrie, Apache II lần lượt là 0,864 và 0,863 trong tiên lượng độ nặng của VTC[8]. ...
Article
Đối tượng và phương pháp: Tiến cứu mô tả, so sánh 3 nhóm đối tượng: 51 BN viêm tụy cấp có tổn thương thận cấp, 168 bệnh nhân viêm tụy cấp không tổn thương thận cấp và 35 người thường khỏe mạnh làm nhóm chứng khỏe mạnh tại Bệnh viện Bạch Mai, từ 10/2021 đến tháng 6/2023. Kết quả: - Trong 51 bệnh nhân viêm tụy cấp có tổn thương thận cấp, 47,1% giai đoạn 1; 33,3% giai đoạn 2; 19,6% giai đoạn 3. - Nồng độ NGAL huyết tương của nhóm viêm tụy cấp có tổn thương thận cấp (570,9 ng/mL) cao hơn nhóm không có tổn thương thận cấp (400,6 ng/mL) và đều lớn hơn nhóm chứng khỏe mạnh (234,3 ng/mL), sự khác biệt có ý nghĩa thống kê. - Giá trị trung vị của NGAL huyết tương tăng dần theo các giai đoạn tổn thương thận cấp, sự khác biệt có ý nghĩa thống kê. - Điểm cắt của NGAL huyết tương 504,29 ng/mL cho độ nhạy 60,8% và độ đặc hiệu là 68,4% (AUC =0,684; p<0,001) trong dự đoán tổn thương thận cấp ở bệnh nhân viêm tụy cấp. - Điểm cắt của NGAL huyết tương là 486,03 ng/mL có độ nhạy là 66,1% và độ đặc hiệu là 66,4% (AUC=0,651; p<0,005) trong tiên lượng độ nặng của viêm tụy cấp. Kết luận: Nồng độ NGAL huyết tương tăng cao và có giá trị tiên lượng ở bệnh nhân viêm tụy cấp có tổn thương thận cấp. Nên sử dụng dấu ấn sinh học NGAL huyết tương để dự báo tổn thương thận cấp ở bệnh nhân viêm tụy cấp.
... As early as 1974,s using CMap,and the results indicated that the expression pro les of drugs-perturbed such as Entecavir, KU-0063794, Y-27632, and Antipyrine were signi cantly negatively correlated with the expression pro les of disease-perturbed, suggesting that these drugs can improve or even stop SAP progress [8].Subsequently, numerous scoring systems based on clinical, imaging, and laboratory indicators, such as Glasgow [9], APACHE II [10], APACHE II [11], APACHE II [12], were developed to evaluate AP severity. While existing scoring systems have played a signi cant role in predicting sustained organ failure in AP, they have limitations,such as requiring multiple statistical parameters, being computationally complex, having a broad time span for required indicators, and exhibiting some lag in assessing disease severity. ...
Preprint
Full-text available
Objective: The etiopathogenesisof severe acute pancreatitis(SAP) remains poorly understood.We aim to investigate the role of immune cells Infiltration Characteristics during SAP progression. Methods/Design:Gene expression profiles of the GSE194331 dataset were retrieved from the GEO. Lasso regression and random forest algorithms were employed to select feature genes from genes related to SAP progression and immune responses. CIBERSORT was utilized to estimate differences in immune cell types and proportions and the relationship between immune cells and gene expression. We performed pathway enrichment analysis using GSEA to examine disparities in KEGG signaling pathways when comparing the two groups. Additionally, CMap analysis was executed to identify prospective small molecular compounds. Results: The three hub genes (CBLB,JADE2,RNF144A) were identified that can predict SAP progression. Analysis of CIBERSORT and TISIDB databases has shown that there are significant differences in immune cell expression levels between the normal and SAP groups, and three hub genes (CBLB,JADE2,RNF144A) were highly correlated with multiple immune cells, regulating the characteristics of immune cell infiltration in the microenvironment.Finally,drug prediction through the Connectivity Map database suggested that compounds such as Entecavir, KU-0063794, Y-27632, and Antipyrine have certain effects as potential targeted drugs for the treatment of SAP. Conclusion: CBLB, JADE2, and RNF144A are hub genes in SAP, potentially playing important roles in SAP progression. This finding further broadens the understanding of the etiopathogenesis of SAP and provides a feasible basis for future research on diagnostic and immunotherapeutic targets for SAP. Strengths and limitations of this study: To find new hub genes related to severe pancreatitis and to suggest the key role of immunoinfiltrating cells in the occurrence and development of severe acute pancreatitis. There is a lack of relevant basic experiments to further verify the pathogenesis of severe acute pancreatitis
Article
Background and Objectives: Acute pancreatitis (AP) is an inflammatory disorder of the pancreas, with severe cases linked to a higher mortality rate. The prognosis of AP is influenced by factors such as necrosis, secondary infections, and organ failure. Tissue damage in AP is driven by the activation of leukocytes and the release of inflammatory mediators. Angiopoietin-like protein 8 (ANGPTL8), also known as betatrophin, is a recently discovered protein that regulates lipid metabolism. This study aimed to investigate the relationship between ANGPTL8 levels and disease severity in AP patients, and to explore the potential of ANGPTL8 as a biomarker. Materials and Methods: This prospective study included 50 patients diagnosed with AP who were admitted to the Department of Internal Medicine at Dr. Cemil Taşcıoğlu City Hospital between September 2021 and February 2022. Additionally, 39 healthy volunteers who underwent a check-up at the same hospital served as the control group. The Glasgow–Imrie (GI) score was used to assess the severity of pancreatitis. Results: ANGPTL8 levels were found to be significantly lower in the AP group compared to the control group, with a statistically significant correlation between ANGPTL8 levels and the severity of AP (p < 0.05). The cut-off level of ANGPTL8 based on the GI score was determined to be 70.9 ng/L. The GI score for ANGPTL8 was 0.749 (95% CI: 0.606–0.861) (p < 0.001). The overall cut-off value for ANGPTL8 was 179.2 ng/L, with an overall classification rate of 0.936 (95% CI: 0.864–0.977) (p < 0.001). Conclusions: This study demonstrates that ANGPTL8 levels vary between patients with and without AP, with lower levels observed in AP patients. Our research is the first to identify decreased ANGPTL8 levels as an independent predictor of AP severity. ANGPTL8 may play a crucial role in regulating inflammation or metabolic dysfunction in AP. However, further studies are needed to confirm these findings in larger populations and investigate ANGPTL8’s mechanistic role in AP. Longitudinal studies could help determine whether ANGPTL8 levels act as a biomarker for disease progression or treatment response, potentially paving the way for targeted therapies to improve outcomes for AP patients.
Article
Acute pancreatitis is a serious inflammatory condition of the pancreas that can lead to significant morbidity and mortality hence, its prevention is a critical aspect of nursing management. Aim: Evaluate the effect of implementing infection prevention and control guidelines for nurses on severity of acute pancreatitis among patients undergoing gastrointestinal endoscopy. Methods: A quasi experimental(study-control) research design was utilized at Al Rajhi Assiut University Hospital. Thirty nurses were currently assigned for giving care for a purposive sample of 100 patients underwent upper gastrointestinal endoscopy, divided equally into control (who had exposed to the routine care) and study group (who had received endoscopic care based on infection prevention and control guidelines). Patient assessment sheet, infection prevention and control observation checklist, and modified Glasgow Imrie Severity Criteria for Acute Pancreatitis were the tools for data collection. Results: Revealed the mean age was slightly insignificant higher in study group (47.0±4.94) than control group (44.56±7.39), therapeutic indication was the predominant (86.0%, 84.0%) in both groups for treating biliary stones which was the most common diagnosis (34.0%, 36.0%) respectively. Also, the study group exhibited significantly better pancreatic biochemical parameters with no pancreatitis (64 % vs. 28% respectively) and fewer severe pancreatitis compared to control group (16% vs. 60%) after implementing infection prevention and control gastrointestinal endoscopy guidelines (p ‹ 0.01). Conclusion: Implementation of infection prevention and control gastrointestinal endoscopy guidelines reduced the severity of acute pancreatitis among patients undergoing gastrointestinal endoscope.
Article
Full-text available
Objective Delirium is a common complication of acute pancreatitis. Receptor-interacting protein kinase 3 (RIP3) is an activator of programmed cell necrosis. This study aimed to determine its ability to predict delirium after acute pancreatitis. Methods In total, 297 patients with acute pancreatitis were prospectively enrolled in this study. Patients were divided into two subgroups (study and validation groups: 197 and 100 cases, respectively). Serum RIP3 levels were measured in all patients and in 100 healthy controls. Acute Physiology and Chronic Health Evaluation (APACHE) II, Ranson, and sequential organ failure assessment (SOFA) scores were used for the severity assessment. In-hospital delirium was observed as an outcome variable. Multifactorial analyses were performed to discern severity correlations and outcome associations. Results Serum RIP3 levels were significantly higher in the patients than in the controls. Serum RIP3 levels had linear relationships under the restricted cubic spline and were independently correlated with APACHE II, Ranson, and SOFA scores. Serum RIP3 levels were linearly correlated with the likelihood of developing in-hospital delirium and exhibited a strong discrimination efficiency under the receiver operating characteristic curve. Serum RIP3 levels, coupled with APACHE II scores, Ranson scores, and SOFA scores, were the four independent predictors of in-hospital delirium. No interactions were revealed regarding its relevance to sex, age, or body mass index in subgroup analysis. These were integrated to form a model graphically represented by a nomogram that showed effective stability, clinical fit, and predictive ability for in-hospital delirium. The model was verified in the validation group. Conclusion An incremental trend in serum RIP3 levels was notable after acute pancreatitis. Serum RIP3 levels are independently related to illness severity and occurrence of in-hospital delirium, indicating that serum RIP3 may be a potential biomarker of acute pancreatitis.
Article
Full-text available
The etiopathogenesis of severe acute pancreatitis (SAP) remains poorly understood. We aim to investigate the role of immune cells Infiltration Characteristics during SAP progression. Gene expression profiles of the GSE194331 dataset were retrieved from the GEO. Lasso regression and random forest algorithms were employed to select feature genes from genes related to SAP progression and immune responses. CIBERSORT was utilized to estimate differences in immune cell types and proportions and the relationship between immune cells and gene expression. We performed pathway enrichment analysis using GSEA to examine disparities in KEGG signaling pathways when comparing the two groups. Additionally, CMap analysis was executed to identify prospective small molecular compounds. The three hub genes (CBLB, JADE2, RNF144A) were identified that can predict SAP progression. Analysis of CIBERSORT and TISIDB databases has shown that there are significant differences in immune cell expression levels between the normal and SAP groups, and three hub genes (CBLB, JADE2, RNF144A) were highly correlated with multiple immune cells, regulating the characteristics of immune cell infiltration in the microenvironment. Finally, drug prediction through the Connectivity Map database suggested that compounds such as Entecavir, KU-0063794, Y-27632, and Antipyrine have certain effects as potential targeted drugs for the treatment of SAP. CBLB, JADE2, and RNF144A are hub genes in SAP, potentially playing important roles in SAP progression. This finding further broadens the understanding of the etiopathogenesis of SAP and provides a feasible basis for future research on diagnostic and immunotherapeutic targets for SAP.
Article
Full-text available
Acute pancreatitis is one of the most commonly encountered etiologies in the emergency setting, with a broad spectrum of findings that varies in severity from mild interstitial pancreas to severe forms with significant local and systemic complications that are associated with a substantial degree of morbidity and mortality. In this article the radiological aspect of the terminology and classification of acute pancreatitis are reviewed. The roles of ultrasound, computed tomography, and magnetic resonance imaging in the diagnosis and evaluation of acute pancreatitis and its complications are discussed. The authors present a practical image-rich guide, applying the revised Atlanta classification system, with the goal of facilitating radiologists to write a correct report, and reinforcing the radiologist’s role as a key member of a multidisciplinary team in treating patients with acute pancreatitis. Computed tomography is the most performed imaging test for acute pancreatitis. Nevertheless, MRI is useful in many specific situations, due to its superiority soft tissue contrast resolution and better assessment of biliary and pancreatic duct, for example in the ductal disconnection. The purpose if this article is to review recent advances in imaging acquisition and analytic techniques in the evaluation of AP.
Article
Full-text available
Acute pancreatitis is one of the most common causes of hospitalisation from gastrointestinal diseases. The causes of pancreatitis vary between countries. Acute pancreatitis is classified based on Revised Atlanta classification 2013 as mild, moderately severe and severe acute pancreatitis. Acute pancreatic severity can be stratified by scoring systems such as Ranson’s score, BISAP score, APACHE-II score, SOFA score. In severe acute pancreatitis, to diagnose, abdominal pain raised amylase or lipase, supported imaging finding and organ failure. Organ failure can be diagnosed by using Modified Marshall Scoring System. Management is started conservatively, which are fluid resuscitation, enteral nutrition, analgesics, and antibiotics. Surgical management is indicated when infected pancreas necrosis is detected. In this review, we will discuss the current management based on recent research.
Article
Full-text available
Abstract BACKGROUND: Severe acute pancreatitis is a subtype of acute pancreatitis, associated with multiple organ failure and systemic inflammatory response syndrome. In this qualitative review we looked at the principles of pathogenesis, classification and surgical management of severe acute pancreatitis. We also looked at the current shift in paradigm in the management of severe acute pancreatitis since the guideline developed by the British Society of Gastroenterology. DATA SOURCES: Studies published between 1st January 1991 and 31st December 2015 were identified with PubMed, MEDLINE, EMBASE and Google Scholar online search engines using the following Medical Subject Headings: “acute pancreatitis, necrosis, mortality, pathogenesis, incidence” and the terms “open necrosectomy and minimally invasive necrosectomy”. The National Institute of Clinical Excellence (NICE) Guidelines were also included in our study. Inclusion criteria for our clinical review included established guidelines, randomized controlled trials and non-randomized controlled trials with a follow up duration of more than 6 weeks. RESULTS: The incidence of severe acute pancreatitis within the UK is significantly rising and pathogenetic theories are still controversial. In developed countries, the most common cause is biliary calculi. The British Society of Gastroenterology, acknowledges the Revised Atlanta criteria for prediction of severity. A newer Determinant-based system has been developed. The principle of surgical management of acute necrotizing pancreatitis requires intensive care management, identifying infection and if indicated, debridement of any infected necrotic area. The current procedures opted for include standard surgical open necrosectomy, endoscopic necrosectomy and minimally invasive necrosectomy. The current paradigm is shifting towards a step-up approach. CONCLUSIONS: Severe acute pancreatitis is still a subject of grey areas in its surgical management even though new studies have been recorded since the origin of the latest UK guidelines for management of severe acute pancreatitis.
Article
Full-text available
Background Acute pancreatitis has a broad clinical spectrum, from mild illness to multiple organ failure and death. Prognostic scores have been developed or adapted to predict disease severity. This study aimed to compare the prognostic scores according to sensitivity and specificity, receiver operating characteristic curves and area under the curve. Statistical correlation with disease severity, length of hospital stay, mortality and complication rates. Methods Retrospective analysis of the clinical data of patients admitted to an Internal Medicine ward with the diagnosis of acute pancreatitis over a ten year period. Evaluation of prognostic scores: Ranson, Glasgow-Imrie, Balthazar, APACHE II (admission and at 48 hours) and C-reactive protein (48 hours), was carried out as well as statistical analysis using Microsoft Excel 2007® and SPSS 16®. The confidence interval used was 95%. Results Data from 193 clinical files was collected. However, 67 were excluded due to lack of information. According to the Atlanta criteria, 90 cases were deemed as mild and 36 severe. The mortality rate was 6% and the local complication rate was 9.3%. Ranson, Glasgow and APACHE II scores had significant correlation with mortality. Apart from C-reactive protein levels at 48 hours, all scores had significant correlation with disease severity. The scores with best area under the curve correlation were APACHE II (48 hours): 0.892, Ranson: 0.879, and APACHE II (admission): 0.861. Conclusions The most accurate prognostic scores in this study were APACHE II (48 hours) and Ranson. APACHE II at admission was a good indicator, impaired only by high false positive ratio.
Article
Abdominal imaging is an important component of the diagnostics of acute pancreatitis. In addition to the clinical features and the laboratory constellation, it serves to establish the diagnosis or the exclusion of other diseases and also the identification and assessment of the course of local complications and vascular changes that can arise during the course of acute pancreatitis. Due to the numerous imaging examination methods that are available, their combination options and the different examination times, there are diverse application options that have to be taken into account, such as the severity and duration of the disease, concomitant diseases and complications of acute pancreatitis. A rational use of imaging is an important prerequisite for high quality and at the same time cost-effective patient care. This review summarizes the current importance of imaging in acute pancreatitis, with particular reference to the updated S3 guidelines on acute pancreatitis.
Article
To the Editor The recent Review of acute pancreatitis¹ should have discussed the superiority of lipase over amylase in its Clinical Presentation and Diagnosis section. In acute pancreatitis, blood lipase levels increase within 3 to 6 hours of symptom onset, peak at 24 hours, and remain elevated for up to 2 weeks; in contrast, amylase levels peak within 3 to 6 hours and persist for only 3 to 5 days. Lipase is also thought to be more specific for the pancreas than amylase due to its relative but not exclusive organ specificity. Because of these characteristics, combined with the fact that time of symptom onset may be unclear or extended, a lipase elevation greater than 3 times the upper limit of normal has been found to have better diagnostic sensitivity for diagnosis of acute pancreatitis than a similar elevation in amylase (64%-100% vs 45%-87%).² Consequently, many studies, in conjunction with the American Board of Internal Medicine’s Choosing Wisely initiative, recommend that lipase should replace amylase for the evaluation of suspected acute pancreatitis.³,4 Considerable laboratory cost savings are associated with a lipase-only policy, and several institutions have demonstrated successful lipase-only test reduction strategies.³,5
Article
Importance: In the United States, acute pancreatitis is one of the leading causes of hospital admission from gastrointestinal diseases, with approximately 300 000 emergency department visits each year. Outcomes from acute pancreatitis are influenced by risk stratification, fluid and nutritional management, and follow-up care and risk-reduction strategies, which are the subject of this review. Observations: MEDLINE was searched via PubMed as was the Cochrane databases for English-language studies published between January 2009 and August 2020 for current recommendations for predictive scoring tools, fluid management and nutrition, and follow-up and risk-reduction strategies for acute pancreatitis. Several scoring systems, such as the Bedside Index of Severity in Acute Pancreatitis (BISAP) and the Acute Physiology and Chronic Health Evaluation (APACHE) II tools, have good predictive capabilities for disease severity (mild, moderately severe, and severe per the revised Atlanta classification) and mortality, but no one tool works well for all forms of acute pancreatitis. Early and aggressive fluid resuscitation and early enteral nutrition are associated with lower rates of mortality and infectious complications, yet the optimal type and rate of fluid resuscitation have yet to be determined. The underlying etiology of acute pancreatitis should be sought in all patients, and risk-reduction strategies, such as cholecystectomy and alcohol cessation counseling, should be used during and after hospitalization for acute pancreatitis. Conclusions and relevance: Acute pancreatitis is a complex disease that varies in severity and course. Prompt diagnosis and stratification of severity influence proper management. Scoring systems are useful adjuncts but should not supersede clinical judgment. Fluid management and nutrition are very important aspects of care for acute pancreatitis.
Article
Acute pancreatitis is common and requires multidisciplinary management. The revised Atlanta classification, published in 2012, defines the terminology necessary to enable specialists from different backgrounds to discuss the morphological and clinical types of acute pancreatitis. Radiologists’ role depends fundamentally on computed tomography (CT), which makes it possible to classify the morphology of this disease and to predict its clinical severity by applying imaging severity indices. Furthermore, CT- or ultrasound-guided drainage is, together with endoscopy, the current technique of choice in the initial approach to collections that appear as a complication. This paper aims to disseminate the concepts coined in the revised Atlanta classification and to describe the current role of radiologists in the diagnosis and treatment of acute pancreatitis.
Article
The incidence of acute pancreatitis continues to increase worldwide, and it is one of the most common gastrointestinal causes for hospital admission in the USA. In the past decade, substantial advancements have been made in our understanding of the pathophysiological mechanisms of acute pancreatitis. Studies have elucidated mechanisms of calcium-mediated acinar cell injury and death and the importance of store-operated calcium entry channels and mitochondrial permeability transition pores. The cytoprotective role of the unfolded protein response and autophagy in preventing sustained endoplasmic reticulum stress, apoptosis and necrosis has also been characterized, as has the central role of unsaturated fatty acids in causing pancreatic organ failure. Characterization of these pathways has led to the identification of potential molecular targets for future therapeutic trials. At the patient level, two classification systems have been developed to classify the severity of acute pancreatitis into prognostically meaningful groups, and several landmark clinical trials have informed management strategies in areas of nutritional support and interventions for infected pancreatic necrosis that have resulted in important changes to acute pancreatitis management paradigms. In this Review, we provide a summary of recent advances in acute pancreatitis with a special emphasis on pathophysiological mechanisms and clinical management of the disorder.
Article
Background and objective The Atlanta classification of acute pancreatitis enabled standardised reporting of research and aided communication between clinicians. Deficiencies identified and improved understanding of the disease make a revision necessary. Methods A web-based consultation was undertaken in 2007 to ensure wide participation of pancreatologists. After an initial meeting, the Working Group sent a draft document to 11 national and international pancreatic associations. This working draft was forwarded to all members. Revisions were made in response to comments, and the web-based consultation was repeated three times. The final consensus was reviewed, and only statements based on published evidence were retained. Results The revised classification of acute pancreatitis identified two phases of the disease: early and late. Severity is classified as mild, moderate or severe. Mild acute pancreatitis, the most common form, has no organ failure, local or systemic complications and usually resolves in the first week. Moderately severe acute pancreatitis is defined by the presence of transient organ failure, local complications or exacerbation of co-morbid disease. Severe acute pancreatitis is defined by persistent organ failure, that is, organ failure >48?h. Local complications are peripancreatic fluid collections, pancreatic and peripancreatic necrosis (sterile or infected), pseudocyst and walled-off necrosis (sterile or infected). We present a standardised template for reporting CT images. Conclusions This international, web-based consensus provides clear definitions to classify acute pancreatitis using easily identified clinical and radiologic criteria. The wide consultation among pancreatologists to reach this consensus should encourage widespread adoption.